Exchange Traded Concepts’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
13,403
+48
+0.4% +$3.27K ﹤0.01% 915
2026
Q1
$863K Sell
13,355
-2,173
-14% -$153K 0.01% 867
2025
Q4
$1.05M Buy
15,528
+2,656
+21% +$179K 0.01% 786
2025
Q3
$944K Buy
+12,872
New +$855K 0.01% 801
2025
Q1
– Sell
-2,397
Closed -$115K – 1334
2024
Q4
$115K Sell
2,397
-399
-14% -$20.5K ﹤0.01% 1125
2024
Q3
$160K Buy
2,796
+1,337
+92% +$76.6K ﹤0.01% 1042
2024
Q2
$76.4K Buy
1,459
+168
+13% +$7.37K ﹤0.01% 955
2024
Q1
$52.5K Sell
1,291
-12,838
-91% -$481K ﹤0.01% 973
2023
Q4
$522K Hold
14,129
– – 0.01% 621
2023
Q3
$540K Buy
14,129
+1,974
+16% +$80.9K 0.02% 583
2023
Q2
$438K Sell
12,155
-402
-3% -$13.7K 0.01% 639
2023
Q1
$480K Buy
12,557
+10,649
+558% +$500K 0.01% 558
2022
Q4
$109K Sell
1,908
-114
-6% -$5.84K ﹤0.01% 756
2022
Q3
$80K Sell
2,022
-7,714
-79% -$341K ﹤0.01% 769
2022
Q2
$428K Buy
+9,736
New +$421K 0.01% 600

Other funds holding HALO

Exchange Traded Concepts's HALO Position: Q2 2026 in Review

Exchange Traded Concepts increased its Halozyme (HALO) stake by 0.36% in Q2 2026, buying an estimated $3.27K and bringing the position to 13,403 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #915.

Exchange Traded Concepts first reported a position in HALO in Q2 2022 and has held it in 15 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Exchange Traded Concepts held 13,403 shares of Halozyme worth $1.05M as of Q2 2026.
  • Exchange Traded Concepts bought 48 Halozyme shares in Q2 2026, an estimated $3.27K.
  • Halozyme made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #915 holding.
  • Exchange Traded Concepts first reported a position in Halozyme in Q2 2022 and has held it in 15 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.